Bryan received an A.B. in Human Developmental and Regenerative Biology at Harvard in 2018. He was an Amgen Scholar at the National Institute of Allergy and Infectious Diseases and a Peer Study Leader in the Harvard Department of Chemistry and Chemical Biology. Bryan’s research focuses on genome editing, viral-mediated gene therapy, and Duchenne muscular dystrophy.